C1q
Reactivity: Human
WB, ELISA, ID
Host: Goat
Polyclonal
unconjugated
Application Notes
Optimal working dilution should be determined by the investigator.
Restrictions
For Research Use only
Format
Liquid
Concentration
10 mg/mL
Hwang, Duvall, Tomlinson, Boackle et al.: "Highly specific inhibition of C1q globular-head binding to human IgG: a novel approach to control and regulate the classical complement pathway using an engineered single chain antibody variable ..." in: Molecular immunology, Vol. 45, Issue 9, pp. 2570-80, (2008) (PubMed).
Cragg, Glennie: "Antibody specificity controls in vivo effector mechanisms of anti-CD20 reagents." in: Blood, Vol. 103, Issue 7, pp. 2738-43, (2004) (PubMed).
Sárvári, Vágó, Wéber, Nagy, Gál, Mák, Kósa, Závodszky, Pázmány: "Inhibition of C1q-beta-amyloid binding protects hippocampal cells against complement mediated toxicity." in: Journal of neuroimmunology, Vol. 137, Issue 1-2, pp. 12-8, (2003) (PubMed).